ArticleBiomedicines2025

Phospholipid-Rich DC-Vesicles with Preserved Immune Fingerprints: A Stable and Scalable Platform for Precision Immunotherapy.

Ramon Gutierrez-Sandoval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.